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1. Introduction
  Diabetes mellitus is a growing threat to public health in 
modern society[1]. It is a metabolic disorder of the pancreas 
in which blood sugar (glucose) levels are abnormally high 
(hyperglycaemia) because either the body does not produce 
enough insulin, the hormone produced by beta cells of the 
islet of Langerhans that controls the amount of sugar in 
the blood[2], or the insulin produced cannot be used by the 
body[3]. While some non insulin dependent diabetic mellitus 
patients can be managed by diet alone, others require 
hypoglycaemic therapy and/or insulin. Although insulin 
therapy affords an effective glycaemic control, drawbacks 
such as oral ineffectiveness, short shelf life, requirement of 
constant refrigeration, parenteral therapy with its attendant 
abscesses and fatal hypoglycaemia in the event of excess 
dosage limit its usage. On the other hand, pharmacotherapy 
with sulphonylureas, biguanides and thiazolidones is 
also associated with side effects[4]. Therefore, there is an 
urgent need to find safe and effective pharmacological 
interventions for diabetes mellitus.
  In recent years, the popularity of complementary medicine 
has increased considerably and the WHO has suggested the 
evaluation of potentials of plants as effective therapeutic 
agents, especially in areas where modern drugs are not 
readily available[4]. Due to their relative safety and low 
costs, herbal medicinal plants are prescribed even when 
they are not standardized[5]. One of the known antidiabetic 
medicinal plants used worldwide is Mucuna pruriens L 
(Fam. Leguminoseae) (M. pruriens) also known as velvet 
beans or Cowitch in English. The local names in Nigeria 
are: Werepe in Yoruba; Karara in Hausa and Agbara in 
Ibo. It is an annual climbing plant indigenous to tropical 
regions, especially Africa, India and the West Indies where 
it is found in bushes, bush paths and hedges. Its flowers 
are white to dark purple and hang in clusters. The plant 
also produces clusters of pods, which contains seeds known 
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as Mucuna beans. Seed pods are covered with reddish-
orange hair-like needles that are readily dislodged and 
can cause intense irritation to the skin. These hairs contain 
mucunain and serotonin and causes itching, blisters and 
dermatitis[6]. The seed is a natural source of L-dopa (about 
7%-10%) and they are also rich in novel alkaloids, saponin 
and sterols[6]. Because of its high L-dopa content it is used 
in the management of Parkinson’s disease and neurological 
illnesses[7]. Various species of Mucuna are grown as a 
minor food crop in Ghana, Mozambique, and Nigeria and 
is still eaten as food during famine and specialty food in 
northeastern India. Raw Mucuna bean seeds are rich in 
minerals especially K, Mg, Ca, and Fe, and contain about 
27% protein[7].
  Seeds of M. pruriens have been shown to possess 
antispasmodic, anti-inflammatory, antipyretic and antivenin 
properties[8-10], aphrodisiac activity[11], and anabolic and 
fertility properties[10]. M. pruriens has been reported to 
be useful in India, Brazil, Spain and Germany, in the 
treatment of diabetes[12]. Although the hypoglycaemic 
effect of the alcohol extract of seeds of M. pruriens has 
been demonstrated in normal[13] and streptozotocin[12] and 
alloxan[13] induced diabetic rats, the anti-hyperglycaemic 
effect was observed only at high doses (200-400 mg/kg/day) 
after 3 weeks and the maximum effect obtained after 15 week 
of daily administration of 200 mg/kg/day was 47%. Moreover, 
effects of the administration of the extract on body weight 
and the acute toxicity of the extract have remained largely 
uninvestigated. Thus, in the present study, the antidiabetic 
properties and acute toxicity of various concentrations of the 
ethanolic seed extract and fractions of M. pruriens has been 
evaluated in normal and alloxan-induced diabetic rats and 
compared with standard hypoglycaemic drug, glibenclamide. 
The ability of M. pruriens extract to reduce body weight loss 
in the diabetic rats has also been evaluated.
2. Materials and methods
2.1. Chemicals 
  Alloxan monohydrate was obtained from Sigma Chemical 
Co. (St. Louis, M.O., USA) and a glibenclamide tablet was 
obtained from the Nigerian-German Chemicals PLC, (Otta, 
Ogun State, Nigeria.). All reagents were of analytical grade. 
2.2. Collection of plant materials and extracts preparation
  Seeds of M. pruriens were collected at Tose village, 
Ibadan, Nigeria and authenticated by the Herbarium Unit 
of the Department of Botany and Microbiology, University 
of Ibadan, Ibadan, Nigeria. A voucher specimen has been 
kept in the herbarium of the Department (Voucher No. UIH 
22305). Seeds of M. pruriens were dried under shade then 
powdered with a milling machine and then sieved (particle 
size of 180 毺m). To prepare the crude ethanolic extract, 100 g
of the ground seed was extracted with 500 mL of ethanol at 
room temperature. The extract was dried and then powdered 
and sieved (particle size 0.18 毺m). A yield of 44% w/w was 
obtained. 
  To prepare the fractions, 10 g of ground seed was 
also successively extracted in chloroform, n-hexane, 
ethylacetate, methanol and ethanol, and dried as described 
for the crude ethanolic extract. A yield of 0.540 g, 0.827 g, 
0.679 g, 1.006 g and 1.009 g was obtained for chloroform, 
n-hexane, ethylacetate, methanol and ethanol, respectively. 
2.3. Animals
  Wistar rats (180-240 g) and albino mice (16-20 g) of 
both sexes were obtained and bred in the animal house 
of the Department of Veterinary Pharmacology, Faculty 
of Veterinary Medicine, University of Ibadan, Ibadan, 
Nigeria. After randomization into various groups, animals 
were acclimatized for a period of 2-3 days before the start 
of experiments. Animals described as fasting had been 
deprived of food for at least 16 h but had been allowed free 
access to drinking water.
2.4. Induction of diabetes
  Diabetes was induced by single intravenous injection of 
120 mg/kg of alloxan monohydrate (dissolved just before use 
in 0.9% normal saline) to overnight fasted rats[14]. Animals, 
in which the development of hyperglycaemia was confirmed 72 h
after the administration of alloxan injection (blood glucose 
level range of 450-500 mg/dL) were used for experiments.
2.5. Acute hypoglycaemic activity
  Sixty Wistar rats were randomly allocated into ten groups 
(A-J) with six rats in each treatment. Group A consisted of 
non treated rats (control), Group B consisted of diabetic 
control rats (alloxan induced diabetic rats), Groups C, D, E, 
F, G, H and I were diabetic rats and 5, 10, 20, 30, 40, 50 and 
100 mg/kg body weight, respectively of the crude ethanolic 
seed extract were administered orally while diabetic rats 
in group J received glibenclamide (5 mg/kg) as standard 
reference drug. Blood glucose levels were measured at 
zero time (before receiving the extract) and at various time 
intervals for 24 h. 
2.6. Chronic hypoglycaemic activity
  For the chronic study, sixty Wistar rats were randomly 
allocated into ten groups (A-J) with six rats in each group. 
Animals in each group were administered with the same 
dose of extracts and standard drug daily as described for 
acute studies. The blood glucose level was measured weekly 
for 12 weeks. The animals were carefully monitored and 
weighed every week.
2.7. Effect of fractions of M. pruriens on diabetic rats
  Thirty diabetic Wistar rats were randomly allocated into 
five groups with six rats in each treatment. Each group 
received 10 mg/kg of the n-hexane, chloroform, ethylacetate, 
methanol and ethanol fractions, respectively and the blood 
glucose level was measured at different time intervals using 
a glucometer (LifeScan Inc. California, USA).   
2.8. Acute toxicity studies 
  In the acute toxicity study, thirty six albino mice were 
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distributed into six groups consisting of 6 rats each. 
Mice were given 2, 4, 6, 8, 16 and 32 g/kg body weight, 
respectively of the ethanol extract of M. pruriens. Doses for 
the extract were selected based on constant logarithm ratio 
of 2. Mice were deprived of food overnight prior to the oral 
administration of the extract and were observed for toxic 
signs, symptoms and mortality for two weeks.
2.9. Statistical analysis
  Data were expressed as mean依SD. Statistical analysis were 
performed using the analysis of variance (ANOVA) followed 
by Tukey post test. Differences were considered to be 
significant when P < 0.05 unless otherwise stated.
3. Results 
  Results of the effect of the crude ethanolic seed extract of 
M. pruriens on the blood glucose level in alloxan-induced 
diabetic rats are presented in Table 1. It showed that the 
administration of 5, 10, 20, 30, 40, 50, and 100 mg/kg of the 
crude ethanolic extract of M. pruriens seed resulted in 18.6%, 
24.9%, 30.8%, 41.4%, 49.7%, 53.1% and 55.4% reduction, 
respectively in blood glucose of the diabetic rats after 8 h of 
treatment while the administration of glibenclamide (5 mg/
kg body weight) resulted in 59.7% reduction. There was a 
significant reduction in the blood glucose level of the rats 
compared with the diabetic standard (P<0.0001). However, 
there were no statistically significantdifferences in the % 
reduction of the blood glucose level when the extract was 
administered at a dose of ≥50mg/kg/day and the standard 
drug, glibenclamide (P>0.05). 
  Result of the effect of chronic administration of M. pruriens 
extracts on the blood glucose level is presented in Table 2 
while the plots of % reduction in the blood glucose level 
versus time (weeks) after chronic administration of different 
concentrations of the extract and standard drug to diabetic 
rats are presented in Figure 1. It indicated that daily 
administration of the extract of M. pruriens seed for 12 weeks 
resulted in a dose-dependent reduction in the blood glucose 
level. Daily administration of 5, 10, 20, 30, 40, 50 and 100 
mg/kg of the extract resulted in 55.2%, 59.5%, 68.4%, 74.7%, 
80.9%, 83.2% and 83.6% reduction in blood glucose level, 
respectively after 12 weeks. On the other hand, the standard 
drug, glibenclamide resulted in 57.8% reduction in the 
plasma glucose levels of the diabetic rats. 
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Figure 1. Plots of % reduction in the blood glucose level versus time 
(weeks) after chronic administration of different concentrations of the 
extract and standard drug to diabetic rats. 
  To determine the activity of fraction of the extract, the 
powdered seed of was subjected to successive extraction with 
n-hexane, chloroform, ethyl acetate, methanol and ethanol 
and the hypoglycaemic effect of these fractions is presented 
in Table 3. It showed that n-hexane, chloroform and ethyl 
acetate fractions possessed no hypoglycaemic activity at the 
dose employed. However, methanol and ethanol fractions 
showed 39.1% and 38.9% reduction in the blood glucose 
level, respectively, 24 h after the administration of extracts. 
  Acute toxicity studies showed that the administration of 
the crude ethanolic extract of M. pruriens seed was well 
tolerated by animals as no death was recorded 14 days after 
the administration of the extract. However, adverse effects 
such as hyperventilation, clonic seizures, pico erection and 
reduced spontaneous motor activity were observed about 1 
hour after the administration of high doses (8-32 g/kg/day). 
  Changes in body weights of diabetic rats after daily 
administration of the crude ethanolic extract of M. pruriens 
seed are shown in Table 4. It indicated that the normal 
Table 1
Effect of ethanolic extract of M. pruriens seeds on the blood glucose level  of alloxan-induced diabetic rats (mg/dL) (Mean 依 SD, n = 6).
Time
(Hour)
Group A
(Normal control) 
Group B
(Diabetic 
control)
Group C 
(5 mg/kg)
Group D 
(10 mg/kg)
Group E 
(20 mg/kg)
Group F
(30 mg/kg)
Group G
(40 mg/kg)
Group H
 (50 mg/kg) 
Group I
(100 mg/kg)
Group J
(Glibenclamide)
0 74.4 依 6.3 455.3  依 1.9△ 455.8 依 4.7 
* 460.4依 2.3* 469.5依 3.2* 486.7 依 8.6* 475.6 依 6.4* 470.7 依 5.6* 452.6 依 5.5* 470.5依3.7*
1 75.6 依 8.2 457.6 依 1.4△ 450.4 依 3.5 * 456.4 依 5.3* 462.4 依9.7* 472.8 依 5.8* 444.8 依 5.4* 460.4 依 5.9* 401.0 依 3.5* 386.4 依 3.5*
2 75.7 依 6.9 459.5 依 2.9△ 450.5 依 4.7 * 448.7 依 4.5* 440.0 依5.6* 435.5 依 3.6* 426.7 依 4.2* 430.8 依 3.1* 381.8 依 3.6* 386.4 依 3.5*
3 69.9 依 7.4 461.6 依 1.5△ 440.5 依 2.7 * 426.4 依 5.2* 427.7 依1.7* 420.7 依 2.3* 402.5 依 5.7* 396.7 依 4.6* 345.5 依 2.7* 364.8 依 3.5*
4 71.3 依 8.4 463.8 依 1.4△ 432.7 依 7.6 * 414.5 依 3.8* 402.6 依4.8* 400.7 依 6.8* 370.5 依 4.6* 363.0 依 6.5* 368.5 依 9.7* 281.7 依 6.4**
5 71.4 依 7.3 465.6 依 2.5△ 423.7 依 5.6 * 400.9 依 4.5* 375.0 依6.9* 377.6 依  4.7* 345.7 依 4.5** 328.9 依 4.5** 324.8 依 4.1** 271.7 依 1.8**
6 77.4 依 7.9 466.9 依 1.9△ 407.8 依 4.7 * 385.7 依 3.6* 357.2 依7.1** 337.6 依 9.5** 310.2 依 7.3** 282.8 依 2.6** 261.7 依 3.9** 241.7 依 9.1**
7 73.9 依10.7 468.4 依 1.1△ 385.5 依 1.5 * 365.5 依 5.1**  342.4 依3.1** 308.7 依 6.4** 275.9 依 7.6** 255.8 依 4.2** 241.4 依 2.7** 210.8 依8.6**
8 70.9 依11.6 470.6 依 1.1△ 370.9 依 2.6 * 345.7 依 2.1** 325.0 依 2.4** 285.2 依 7.2** 239.2 依 8.6** 220.6 依 4.9** 201.7 依 3.7** 189.7 依 5.6**
24 76.7 依9.8 474.3 依 4.1△ 351.2 依 1.8 * 327.3 依 3.2** 300.0 依 3.2** 254.7 依 5.4** 202.5 依 6.7** 185.5 依 4.2** 171.2 依 2.8** 165.8 依 2.4**
△:P<0.05, vs. Group A; *:  P<0.05, **: P<0.01, vs. Group B. 
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control showed 27% weight gain while diabetic control 
rats exhibited 27% weight loss over the 12 weeks period. 
However, rats that were administered with the extracts 
exhibited 16%-40% weight gain while those administered 
with glibenclamide (5 mg/kg) showed 18% weight gain. The 
weight gain observed with the extract depended on the dose 
administered. This indicates that treatment with M. pruriens 
seed extract significantly alleviated the weight loss in 
diabetic rats in a similar manner to glibenclamide (P<0.001). 
4. Discussion
  Beside drugs classically used for the treatment of diabetes, 
several species of plants have been described as having a 
hypoglycaemic activity[14-16]. These herbal medicines have 
Table 2
Effect of chronic administration of ethanol extract of M. pruriens seeds on blood glucose level  of alloxan-induced diabetic rats (mg/dL) (mean 依 
SD, n = 6).
Time
Week)
Group A
(Normal control) 
Group B 
(Diabetic 
control)
Group C 
(5 mg/kg)
Group D
(10 mg/kg)
Group E 
(20 mg/kg)
Group F
(30 mg/kg)
Group G
(40 mg/kg)
Group H 
(50 mg/kg) 
Group I
(100 mg/kg)
Group J
(Glibenclamide)
1 77.5 依 0.5 461.9 依 7.4 464.5 依 5.4 464.2 依 4.3 454.8 依 5.3 470.7 依 4.7 459.8 依 6.7 467.8 依 8.6 470.6 依 9.7 470.3 依 7.1
2 75.9 依 0.6 468.6 依 6.4 450.5 依 2.4 436.6 依 3.6 430.6 依 2.1 448.6 依 5.7 440.9 依 4.7 454.5 依 5.4 449.8 依 2.4  450.1依 4.0
3 78.6 依 0.6 474.5 依 4.5 440.7 依 3.8 409.5 依 7.5 405.9 依 3.4 418.5 依 6.8 416.8 依 5.8 430.9 依 1.4 418.2 依 8.9 451.2 依 8.9
4 78.5 依 0.2 480.6 依 5.7 419.6 依 6.5 386.6 依 4.6 382.9 依 4.1 388.8 依 8.5 384.7 依 6.8 410.7 依 2.4 375.4 依 3.4 432.9 依 7.4
5 74.8 依 1.4 487.4 依 6.3 393.8 依 4.8 369.8 依 4.3 350.3 依 6.9 340.4 依 7.5 357.5 依 4.8 354.9 依 3.6 323.7 依 7.1 400.1 依 3.5
6 76.8 依1.2 495.0 依 3.2 380.5 依 3.5 347.7 依 5.7 320.9 依 5.8 305.7 依 4.8 316.9 依 6.4 335.4 依 7.6 280.8 依 2.7 385.5 依 4.8
7 77.9 依 2.4 502.2 依 4.6 360.7 依 3.2 333.7 依 4.3 276.7 依 4.8 284.2 依 8.3 260.6 依 7.4 287.7 依 1.4 235.2 依 4.1 342.1 依 5.3
8 78.3 依 3.2 509.4 依 6.4 328.7 依 6.3 303.4 依 5.4 240.7 依 9.6 256.7 依 8.5 218.9 依 4.3 246.2 依 2.3 193.4 依 5.4 319.8 依 7.8
9 78.6 依 1.3 517.8 依 5.7 287.9 依 8.5 260.8 依 4.9 215.8 依 4.9 224.9 依 9.6 182.9 依 5.6 192.4 依 0.1 165.6 依 7.1 287.7 依 6.6
10 75.8 依 1.2 525.8 依 4.3 257.8 依 7.3 230.6 依 7.5 179.9 依 1.5 184.7 依 5.3 148.8 依 4.8 165.9 依 1.4 130.4 依 4.6 231.4 依 4.5
11 76.5 依 1.3 535.9 依 6.5 238.8 依 7.5 217.8 依 4.4 155.3 依 1.4 141.4 依 7.4 118.5 依 6.5 127.6 依 4.4 100.4 依 4.6 219.7 依 2.4
12 78.7 依 1.4 545.6 依 6.3 207.7 依 4.8 187.8 依 5.9 143.8 依 0.6 119.2  依 3.1   87.9 依 6.2   78.7 依 2.4   77.4 依 3.7 198.7 依 6.2
Values are statistically significant at P < 0.001 when alloxan treated was compared with the normal control and experimental groups. 
 
Table 3
Effect of crude fractions of M. pruriens seeds on blood glucose level  on alloxan-induced diabetic rats (mg/dL) (mean 依 SD, n = 6).
Time (hour) n-hexane Chloroform Ethylacetate Methanol Ethanol
         0 455.5 依 0.4 456.2 依 0.7 456.8 依 0.5 466.7 依 0.3 460.1 依 0.2
         1 455.5 依 1.2 457.1 依 1.4 457.2 依 0.9 447.7 依 0.2 451.5 依 2.3
         2 456.6 依 2.4 457.6 依 1.3 457.7 依 0.3 438.3 依 2.7 440.2 依 1.0
         3 456.4 依 0.8 456.4 依 1.3 458.7 依 2.1 430.4 依 0.3 433.9 依 3.4
         4 457.2 依 0.4 457.2 依 1.3 458.6 依 1.6 387.2 依 0.7 382.1 依 0.5
         5 457.3 依 1.4 457.3 依 0.5 459.6 依 4.6 387.5 依 2.4 382.6 依 2.6
         6 456.1 依 0.7 458.6 依 3.7 460.3 依 7.8 362.7 依 1.5 337.7 依 5.7
         7 458.8 依 0.4 458.4 依 2.7 460.4 依 6.3 324.6 依 4.2 337.7 依 3.5
         8   458.5 依 0.3 459.2 依 1.3 459.6 依 7.3 300.6 依 3.6 305.2 依 3.8
        24 464.5 依 1.6 463.7 依 0.6 460.5 依 1.2 284.3 依 4.3 281.3 依 2.6
 
Table 4 
Effect of chronic administration of ethanol extract of M. pruriens seeds on the body weight of diabetic rats (mean 依 SD, n = 6).
Time
(Week)
Group A 
(Normal 
control) 
Group B 
(Diabetic 
control)
Group C
(5 mg/kg)
Group D
(10 mg/kg)
Group E
(20 mg/kg)
Group F
(30 mg/kg)
Group G
(40 mg/kg)
Group H
(50 mg/kg) 
Group I
(100 mg/kg)
Group J
(Glibenclamide)
0 163.2依11.5 225.0依7.9 192.0依10.5 220.0依12.5 195.0依14.6 190.0依10.0 226.5依16.4 235.0依9.9 237.2依3.2 193.0依14.5
1 165.3依13.6 223.5依14.7 193.2依11.7 224.2依13.2 198.8依12.7 195.7依14.7 231.4依13.6 237.2依11.7 238.5依4.5 194.2依1.5
2 168.3依10.5 220.2依8.9 197.4依13.7 228.3依9.4 205.8依8.9 220.6依7.6 237.3依11.6 240.0依14.5 241.3依6.3 196.2依9.9
3 170.2依11.6 218.9依9.9 199.3依12.5 231.9依11.6 210.8依11.3 227.6依11.5 242.4依8.9 242.3依12.4 244.2依10.3 198.3依9.5
4 175.2依7.9 214.0依11.8  2033依12.5 234.8依14.6 214.2依13.6 234.7依9.7 256.4依13.7 244.3依13.7 246.4依9.4 201.2依14.5
5 178.2依11.8 211.4依14.8 208.3依11.5 237.0依11.2 217.4依9.7 238.5依11.5 260.3依11.3 246.3依11.8 250.2依10.2 204.1依11.4
6 183.1依10.7 202.8依13.5 214.2依13.8 242.8依14.6 224.4依14.5 243.7依14.7 266.4依12.8  2492依14.6 254.2依8.6 206.2依12.4
7 187.4依13.6 189.8依9.9 218.0依9.6 246.5依14.7 229.4依12.9 246.9依9.9 271.3依13.5  2541依13.5 256.5依7.5 211.2依14.3
8 193.9依11.3 182.0依11.8 223.2依10.7 249.0依12.6 236.3依14.1 252.5依13.5 275.2依9.7 258.2依9.7 258.2依8.9 216.3依9.4
9 197.3依14.7 177.6依12.8 226.2依11.7 255.8依9.6 239.3依14.4 257.7依12.7 279.2依13.5 265.0依14.5 260.2依9.6 219.4依13.8
10 201.2依13.6 171.5依13.7 230.4依12.8 258.2依10.5 246.8依12.8 261.2依8.9 283.4依14.6 269.0依13.3 263.2依10.3 223.5依14.3
12 207.8依14.9 165.0依11.8 234.0依14.5 263.3依15.6 251.8依11.8 266.4依15.5 286.3依12.8 273.2依12.5 265.4依9.7 227.2依13.5
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been recommended for the treatment of diabetes and are 
considered less toxic with fewer side effects than synthetic 
ones[15].
  The administration of single dose of the ethanolic extract 
of M. pruriens resulted in a significant reduction in the 
blood glucose level of the diabetic rats when compared 
with diabetic rats that received no treatment(P<0.001). 
The hypoglycaemic effect was found to be dose dependent 
with the administration of 5, 10, 20, 30, 40, 50 and 100 mg/
kg of the extract to diabetic rats resulting in 22.9%, 28.9%, 
36.1%, 47.7%, 57.4%, 60.6% and 62.2% reduction in blood 
glucose, respectively, 24 hours after the administration while 
glibenclamide resulted in 64.8% reduction in the blood 
glucose level. Antidiabetic effects of extracts at high doses 
(50 mg/kg/day and above) is comparable with effects of 
glibenclamide (5 mg/kg).
  The extract exhibited a significant  dose dependent 
reduction in the blood glucose level after chronic 
administration(P<0.001). The maximum hypoglycaemic 
effect (83.6% reduction) was achieved by the extract at a 
dose of 100 mg/kg.  Furthermore, daily administration of 5 
mg/kg of the extract for 12 weeks resulted in 55.3% reduction 
in blood glucose level which is similar to the effect achieved 
by glibenclamide (5 mg/kg/day). There was a significant 
difference between effects of chronic administration of the 
extract at high doses (50 mg/kg and above) and those of 
glibenclamide (5 mg/kg) (P<0.001). Thus, the extract appears 
to have a stronger ability to reduce the blood glucose level 
after long term use than glibenclamide. The hypoglycaemic 
effect obtained in this study is significantly higher than 
those reported by Rathi et al[12], who obtained a maximum 
hypoglycaemic effect of 47.7% after 15 weeks of daily 
administration of 200 mg/kg/day of the alcohol extract of 
M. pruriens obtained in India. Variations due to weather 
conditions, maturity of the plant and soil composition 
significantly affect the pharmacological properties of herbs 
and therefore the actual dose of active ingredient[17]. The 
hypoglycaemic effect of the M. pruriens seed was found 
to reside in methanol and ethanolic fractions. n-hexane, 
chloroform and ethyl acetate fractions did not have any 
antidiabetic effects. 
  Diabetes is often associated with the characteristic loss 
of body weight which is partially due to increased muscle 
wasting[18]. Treatment of diabetic rats with the extract 
was also led to a reduction in the weight loss usually 
associated with diabetes. The rats exhibited a significant 
dose dependent weight gain similar to those achieved by 
the normal rats and those receiving the standard drug, 
glibenclamide(P<0.001).
  The study indicates that the ethanolic seed extract of M. 
pruriens possess antidiabetic activities comparable with the 
standard drug, glibenclamide. Acute toxicity studies showed 
that the extract was relatively safe except at high doses when 
some adverse effects were observed although no death was 
recorded. Furthermore, oral administration of M. pruriens 
seed extract also reduced the weight loss associated with 
diabetes. The study clearly supports the traditional use of 
the plant for the treatment of diabetes.
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